Evidence for different mechanisms of EMT-6 tumor necrosis by photodynamic therapy with disulfonated aluminum phthalocyanine or photofrin: Tumor cell survival and blood flow

Anticancer Research

Volumn 16, Issue 4 A, 1996, Pages 1887-1892

  Chan, Wai Shun ^a   Brasseur, Nicole ^a   La Madeleine, Carole ^a   Van Lier, Johan E ^a  

^a UNIVERSITY OF SHERBROOKE   (Canada)

Author keywords

Blood flow; Clonogenicity; EMT 6 tumor; Photodynamic therapy; Photofrin; Phthalocyanine

Indexed keywords

PHOTOFRIN; PHOTOSENSITIZING AGENT; PHTHALOCYANINE ALUMINUM;

ANIMAL CELL; ARTICLE; CELL SURVIVAL; CELL VIABILITY; CLONOGENESIS; DRUG MECHANISM; MOUSE; NONHUMAN; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; TUMOR BLOOD FLOW; TUMOR CELL; TUMOR NECROSIS;

ANIMALS; ANTINEOPLASTIC AGENTS; CELL LINE; CELL SURVIVAL; DIHEMATOPORPHYRIN ETHER; FEMALE; INDOLES; LIGHT; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; NECROSIS; ORGANOMETALLIC COMPOUNDS; PHOTOCHEMOTHERAPY; RADIATION-SENSITIZING AGENTS; REGIONAL BLOOD FLOW; TIME FACTORS; TUMOR CELLS, CULTURED; TUMOR STEM CELL ASSAY;

EID: 0029783249     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Dougherty TJ: Yearly review: Photodynamic therapy. Photochem Photobiol 58: 895-900, 1993.
2. Brasseur N, Ali H, Autenrieth D, Langlois R and van Lier JE: Biological activities of phthalocyanines-III. Photoinactivation of V-79 Chinese hamster cells by tetrasulfophthalocyanines. Photochem Photobiol 42: 515-521, 1985.
3. Chan WS, Svensen R, Phillips D and Hart IR: Cell uptake, distribution and response to aluminium chloro sulphonated phthalocyanine, a potential anti-tumour photosensitizes Br J Cancer 53: 255-263, 1986.
4. Ben-Hur E and Rosenthal I: The phthalocyanines: a new class of mammalian cells photosensitizers with a potential for cancer phototherapy. Int J Radiat Biol 47: 135-147, 1985.
5. Bown SG, Tralau CJ, Coleridge Smith PD, Akdemis D and Wieman TJ: Photodynamic therapy with porphyrin and phthalocyanine sensitisation: quantitative studies in normal rat liver. Br J Cancer 54: 43-52, 1986.
6. Ali H, Langlois R, Wagner JR, Brasseur N, Paquette B and van Lier JE: Biological activities of phthalocyanines-X. Synthesis and analyses of sulfonated phthalocyanines. Photochem Photobiol 47: 713-717, 1988.
7. Ben-Hur E and Rosenthal I: Photosensitization of Chinese hamster cells by water-soluble phthalocyanines. Photochem Photobiol 43: 615-619, 1985.
8. Brasseur N, Ali H, Langlois R, Wagner JR, Rousseau J and van Lier JE: Biological activities of phthalocyanines-V. Photodynamic therapy of EMT6 mammary tumors in mice with sulfonated phthalocyanines. Photochem Photobiol 45: 581-586, 1987.
9. Chan WS, Marshall JF and Hart IR: Photodynamic therapy of a murine tumor following sensitization with chloro aluminum sulfonated phthalocyanine. Photochem Photobiol 46: 867-871, 1987.
10. Tralau CJ, Mac-Robert AJ, Coleridge-Smith PD, Barr H and Bown SG: Photodynamic therapy with phthalocyanine sensitization: quantitative studies in a transplantable rat fibrosarcoma. Br J Cancer 55: 389-395, 1987.
11. Chan WS, Marshall JF, Svensen R, Bedwell J and Hart IR: Effect of sulfonation on the cell and tissue distribution of the photosensitizer aluminum phthalocyanine. Cancer Res 50: 4533-4538, 1990.
12. Chan WS, West CML, Moore JV and Hart IR: Photocytotoxic efficacy of sulphonated species of aluminium phthalocyanine against cell monolayers, multicellular spheroids and in vivo tumours. Br J Cancer 64: 827-832, 1991.
13. Paquette B, Ali H, Langlois R and van Lier JE: Biological activities of phthalocyanines-VIII. Cellular distribution in V-79 Chinese hamster cells and phototoxicity of selectively sulfonated aluminum phthalocyanines. Photochem Photobiol 47: 215-220, 1988.
14. Paquette B and van Lier JE: Phthalocyanines and related compounds: Structure-activity relationships. In: Photodynamic Therapy: Basic Principles and Clinical Aspects (Henderson BW and Dougherty TJ, eds). Marcel Dekker, New York, 1992, pp 145-156.
15. Margaron P, Grégoire M-J, Scasnár V, Ali H and van Lier JE: Structure-photodynamic activity relationships of a series of 4-substituted zinc phthalocyanines. Photochem Photobiol 63: 217-223, 1996.
16. van Bruggen N, Chan WS, Syha J, Marshall JF, Proctor E, Williams SR, Gadian DG and Hart IR: Cell and tissue response of a murine tumour to phthalocyanine-mediated photodynamic therapy. Eur J Cancer 28: 42-46, 1992.
17. Nelson JS, Liaw L-H, Orenstein A, Roberts WG and Berns MW: Mechanism of tumor destruction following photodynamic therapy with hematoporphyrin derivative, chlorin, and phthalocyanine. J Natl Cancer Inst 80: 1599-1605, 1988.
18. Henderson BW and Dougherty TJ: How does photodynamic therapy work? Photochem Photobiol 55: 145-157, 1992.
19. Zhou C: Mechanisms of tumor necrosis induced by photodynamic therapy. J Photochem Photobiol (B) 3: 299-318, 1989.
20. Peng Q, Moan J, Nesland JM and Rimington C: Aluminum phthalocyanines with asymmetrical lower sulfonation and with symmetrical higher sulfonation: a comparison of localizing and photosensitizing mechanism in human tumor LOX xenografts. Int J Cancer 46: 719-726, 1990.
21. Margaron P, Madarnas P, Quellet R and van Lier JE: Biological activities of phthalocyanines. XVII Histopathologic evidence for different mechanisms of EMT-6 tumor necrosis induced by photodynamic therapy with disulfonated aluminum phthalocyanine or Photofrin. Anticancer Res, 1996, in press.
22. Fingar VH, Wieman TJ, Siegel KA, Karavolos PS, Doak KW, Ouellet R and van Lier JE: The effects of photodynamic therapy using zinc phthalocyanines on vessel constriction, vessel leakage and tumour response. Photochem Photobiol 58: 251-259, 1993.
23. van Leengoed HLLM, van der Veen N, Versteeg AAC, Ouellet R, van Lier JE and Star WM: In vivo photodynamic effects of phthalocyanines in a skin fold observation chamber model: Role of central metal ion and degree of sulfonation. Photochem Photohiol 58: 575-580, 1993.
24. Bellnier DA, Ho Y-K, Pandey RK, Missert JR and Dougherty TJ: Distribution and elimination of Photofrin II in mice. Photochem Photobiol 50: 221-228, 1989.
25. 99mTc myocardial perfusion imaging. Curr Opin Radiol 3: 810-816, 1991.
26. Henderson BW, Waldow SM, Mang TS, Potter WR, Malone PB and Dougherty TJ: Tumour destruction and kinetics of tumour cell death in two experimental mouse tumors following photodynamic therapy. Cancer Res 45: 572-576, 1985.
27. Nelson JS, Wright WH and Berns MW: Histopathological comparison of the effects of hematoporphyrin derivative on two different murine tumors using computer-enhanced digital video fluorescence microscopy. Cancer Res 45: 5781-5786, 1985.
28. Winther J: Photodynamic therapy effect in an intraocular retinoblastoma-like tumour assessed by an in vivo to in vitro colony forming assay. Br J Cancer 59: 869-872, 1989.
29. Chaudhuri K, Keck RW and Selman SH: Morphological changes of tumor microvasculature following hematoporphyrin derivative sensitized photodynamic therapy. Photochem Photobiol 46: 823-827, 1987.
30. Fingar VH, Wieman T, Wiehle S and Cerrito PB: The role of microvascular damage in photodynamic therapy: the effect of treatment on vessel constriction, permeability, and leukocyte adhesion. Cancer Res 52: 4914-4921, 1992.
31. 99 Technetium HMPAO scintigraphy. Br J Cancer 65: 491-497, 1992.
32. Selman SH, Kreimer-Birnbaum M, Klaunig JE, Goldblatt PJ, Keck RW and Britton SL: Blood flow in transplantable bladder tumors treated with hematoporphyrin derivative and light. Cancer Res 44: 1924-1927, 1984.
33. Star WM, Marijnissen JPA, van den Berg-Blok AE, Versteeg AAC, Franken NAP and Reinhold HS: Destruction of rat mammary tumor and normal tissue microcirculation by hematoporphyrin derivative photoradiation observed in vivo in sandwich observation chambers. Cancer Res 46: 2532-2540, 1986.
34. van Geel IPJ, Oppelaar H, Oussoren YG and Stewart FA: Changes in perfusion of mouse tumors after photodynamic therapy. Int J Cancer 56: 224-228, 1994.
35. Bremner JCM, Adams GE, Pearson JK, Sansom JM, Stratford IJ, Bedwell J, Bown SG, MacRobert AJ and Phillips D: Increasing the effect of photodynamic therapy on the RIF-1 murine sarcoma, using the bioreductive drugs RSU1069 and RB6145. Br J Cancer 66: 1070-1076, 1992.
36. Bugelski PJ, Porter CW and Dougherty TJ: Autoradiographic distribution of hematoporphyrin derivative in normal and tumor tissue of the mouse. Cancer Res 41: 4606-4612, 1981.
37. Henderson BW and Fingar VH: Oxygen limitation of direct tumor cell kill during photodynamic treatment of a murine tumor model. Photochem Photobiol 49: 299-304, 1989.